Octave Specialty Group
OSG · NYSE
About OSG
- Employees
- 275
- Headquarters
- New York City, New York
- Listed
- Jul 10, 1991
- Sector
- Financials
- Industry
- Insurance
- Website
- octavegroup.com
OSG key statistics
- Market cap
- 208.14M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 493.23K
- Volume
- 158.00K
- Open price
- $4.63
- High today
- $4.76
- Low today
- $4.63
- 52 Week high
- $10.38
- 52 Week low
- $3.88
Octave Specialty Group (OSG) at a glance
Octave Specialty Group (OSG) last traded at $4.75, with a market cap of 208.14M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $4.63 and $4.76. The current price is 2.6% above the day's low and 0.2% below its high.
Volume so far is 158.00K shares, below the average of 493.23K shares a day.
Over the past year Octave Specialty Group has ranged from $3.88 to $10.38, and now sits 13% of the way up that range.
Octave Specialty Group met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.04 per share against an estimate of -$0.0051.
OSG earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 610.8% on average.
- Q3 FY24: reported -$0.46 per share against an estimate of $0.0842
- Q4 FY24: reported -$0.12 per share against an estimate of $0.00
- Q1 FY25: reported -$0.13 per share against an estimate of -$0.0707
- Q2 FY25: reported -$0.22 per share against an estimate of -$0.2424
- Q3 FY25: reported -$0.21 per share against an estimate of -$0.2323
- Q4 FY25: reported -$0.02 per share against an estimate of -$0.2071
- Q1 FY26: reported $0.37 per share against an estimate of $0.0152
- Q2 FY26: reported -$0.04 per share against an estimate of -$0.0051
OSG news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Pivix Launches Monoline Commercial Property Program
- Press releaseBusiness Wire
E&S MGA Pivix Launches Assault & Battery Program
- Press releaseBusiness Wire
Octave Specialty Group Appoints Philip Stefano Head of Investor Relations
- Press releaseBusiness Wire
AM Best Affirms Credit Ratings of Everspan Indemnity Insurance Company and Its Affiliates
- Press releaseBusiness Wire
Octave Specialty Group Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Everspan Group Expands Leadership Team with Three Senior Appointments
- Press releaseBusiness Wire
Octave Specialty Group to Release Second Quarter 2026 Results on August 6, 2026
Similar companies
Companies in the same industry as Octave Specialty Group
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.